Discovery of (5-Phenylfuran-2-yl)methanamine Derivatives as New Human Sirtuin 2 Inhibitors
Human sirtuin 2 (SIRT2), a member of the sirtuin family, has been considered as a promising drug target in cancer, neurodegenerative diseases, type II diabetes, and bacterial infections. Thus, SIRT2 inhibitors have been involved in effective treatment strategies for related diseases. Using previousl...
Main Authors: | Lijiao Wang, Chao Li, Wei Chen, Chen Song, Xing Zhang, Fan Yang, Chen Wang, Yuanyuan Zhang, Shan Qian, Zhouyu Wang, Lingling Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/15/2724 |
Similar Items
-
Sirtuin as the target of anti-cancer therapy
by: Marzena Baran, et al.
Published: (2020-08-01) -
Sirtuins 1 and 2 in the Acute Period After Photothrombotic Stroke: Expression, Localization and Involvement in Apoptosis
by: Moez Eid, et al.
Published: (2022-04-01) -
The human sirtuin family: Evolutionary divergences and functions
by: Vassilopoulos Athanassios, et al.
Published: (2011-07-01) -
Antagonistic Pharmacological Interaction between Sirtuin Inhibitor Cambinol and Paclitaxel in Triple-Negative Breast Cancer Cell Lines: An Isobolographic Analysis
by: Anna Wawruszak, et al.
Published: (2022-06-01) -
Mammalian Sirtuins and Their Relevance in Vascular Calcification
by: Xinyue Pan, et al.
Published: (2022-05-01)